Last Update Time:
12-Mar-2025 16:00:00
ISIN:
INE326A01037
Sector:
Healthcare
Symbol:
LUPIN
Lupin Limited
₹1,966.70
₹-9.40
(-0.48%)
▼
Prev. Close
₹1,976.10
Open
₹1,976.10
Close
₹1,966.70
Range
₹1,868.37 - ₹2,065.04
High
₹1,986.50
Low
₹1,937.40
Ind. Close
₹0.00
VWAP
₹1,957.27
The current stock price of Lupin Limited is ₹1,966.70, with a target price range between ₹1,868.37 and ₹2,065.04. The stock has experienced a price change of ₹-9.40 (-0.48%), reflecting recent market volatility.
Today's opening price was ₹1,976.10, while the previous close stood at ₹1,976.10.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Lupin Limited Price Chart
Lupin Limited Pre Open Market Overview: 12-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 1976.1
- Previous Close Price: 1976.1
- Change: 0.00%
- Total Traded Volume: 512
- Total Buy Quantity: 3,603
- Total Sell Quantity: 9,304
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 1,974.50 | 250.00 | 0.00 |
| 1,975.00 | 65.00 | 0.00 |
| 1,975.10 | 20.00 | 0.00 |
| 1,976.00 | 140.00 | 0.00 |
| 1,976.10 | 90.00 | 0.00 |
| 1,982.00 | 0.00 | 100.00 |
| 1,988.00 | 0.00 | 15.00 |
| 1,995.00 | 0.00 | 1,000.00 |
| 1,995.95 | 0.00 | 1.00 |
| 1,996.00 | 0.00 | 24.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 3603
Total Sell Quantity: 9304
Shareholding Patterns of Lupin Limited
Key Trade Statistics of Lupin Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 5.77 |
| Traded Value (₹ Cr.) | 112.90 |
| Total Market Cap (₹ Cr.) | 89,787.91 |
| Free Float Market Cap (₹ Cr.) | 47,379.64 |
| Impact cost | 0.03 |
| Quantity Traded | 576,820.00 |
| Deliverable Quantity | 311,908.00 |
| % of Quantity to Traded | 54.07 |
| Security VaR | 10.97 |
| Index VaR | N/A |
| VaR Margin | 10.97 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 14.47 |
| Face Value | 2 |
Key Price Statistics of Lupin Limited
The 52-week high for Lupin Limited was ₹2,402.90, recorded on 02-Jan-2025. On the other hand, the 52-week low stands at ₹1,493.30, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹2,173.70, and the lower band is ₹1,778.50. The price band is No Band%.
The stock's daily volatility stands at 1.73, while the annualized volatility is 33.05. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (02-Jan-2025) | 2,402.90 |
| 52 Week Low (04-Jun-2024) | 1,493.30 |
| Upper Band | 2,173.70 |
| Lower Band | 1,778.50 |
| Price Band (%) | No Band |
| Daily Volatility | 1.73 |
| Annualised Volatility | 33.05 |
| Tick Size | 0.05 |
Key Securities Statistics of Lupin Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 10-Sep-2001 |
| Adjusted P/E | 31.19 |
| Symbol P/E | 31.19 |
| Index | NIFTY MIDCAP 50 |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Lupin Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Lupin Limited
| Subject | Date |
|---|---|
| Press Release | 07-Mar-2025 |
| Alteration Of Capital and Fund Raising-XBRL | 27-Feb-2025 |
| ESOP/ESOS/ESPS | 27-Feb-2025 |
| Press Release | 27-Feb-2025 |
| Press Release | 21-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 19-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 19-Feb-2025 |
| Copy of Newspaper Publication | 19-Feb-2025 |
Corporate Actions of Lupin Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 2 | Dividend - Rs 8 Per Share | 16-Jul-2024 |
| 2 | Dividend - Rs 4 Per Share | 14-Jul-2023 |
| 2 | Dividend - Rs 4 Per Share | 14-Jul-2022 |
| 2 | Dividend - Rs 6.50 Per Share | 27-Jul-2021 |
| 2 | Annual General Meeting/Dividend - Rs 6 Per Share | 03-Aug-2020 |
| 2 | Annual General Meeting/Dividend - Rs 5 Per Share | 29-Jul-2019 |
| 2 | Annual General Meeting/Dividend Rs 5/- Per Share | 30-Jul-2018 |
| 2 | Annual General Meeting/Dividend - Rs 7.50 Per Share | 24-Jul-2017 |
| 2 | Annual General Meeting/ Dividend -Rs 7.50/- Per Share | 25-Jul-2016 |
| 2 | Annual General Meeting/ Dividend - Rs 7.50/- Per Share | 14-Jul-2015 |
| 2 | Annual General Meeting / Final Dividend - Rs 3/- Per Share | 21-Jul-2014 |
| 2 | Interim Dividend - Rs 3/- Per Share | 13-Feb-2014 |
| 2 | Annual General Meeting / Dividend - Rs 4/- Per Share | 29-Jul-2013 |
| 2 | Annual General Meeting And Dividend Rs.3.20 Per Share | 13-Jul-2012 |
| 2 | Annual General Meeting And Dividend Rs.3/- Per Share | 18-Jul-2011 |
| 2 | Face Value Split From Rs.10/- To Rs.2/- | 27-Aug-2010 |
| 2 | Annual General Meeting And Dividend Rs.13.50 Per Share | 19-Jul-2010 |
| 2 | Agm/Div-Rs.12.50 Pr Share | 20-Jul-2009 |
| 2 | Agm/Div-50% + Spl Div-50% | 11-Jul-2008 |
| 2 | Agm/Dividend-50% | 10-Jul-2007 |
Board Meetings of Lupin Limited
Financial Results of Lupin Limited
Company Directory of Lupin Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.lupin.com | Head Office/ Corporate Office | Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), | MUMBAI |
| www.lupin.com | Registered Office | 3rd Floor, Kalpataru Inspire off. W. E. Highway Santacruz (East) | MUMBAI |
| www.lupin.com | Transfer Agent | MUFG Intime India Private Limited C 101, 247 Park, LBS Marg, Vikhroli (W) MUMBAI - 400083 | MUMBAI |
Insider Trading of Lupin Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Dr. Kamal K Sharma | 14775000 | Sell |
| 7(2) | MR. NILESH D. GUPTA | 0 | Sell |
| 7(2) | MR. NEEL DESHBANDHU GUPTA | 0 | Buy |
| 7(2) | Veda Nilesh Gupta | 0 | Buy |
| 7(2) | MR. NILESH D. GUPTA | 5000974 | Buy |
| 7(2) | SUNIL MAKHARIA | 19480000 | Sell |
| 7(2) | Ramesh Swaminathan | 9780000 | Sell |
| 7(2) | MR. NILESH D. GUPTA | 0 | Sell |
| 7(2) | Veda Nilesh Gupta | 0 | Buy |
| 7(2) | SUNIL MAKHARIA | 2322000 | Sell |
| 7(2) | Naresh Kumar Gupta | 3489150 | Sell |
| 7(2) | Debabrata Chakravorty | 3474910 | Sell |
| 7(2) | MR. NILESH D. GUPTA | 2483660 | Buy |
| 7(2) | Dr. Rajender Kumar Kamboj | 14024000 | Buy |
| 7(2) | Dr. Kamal K Sharma | 20786500 | Buy |
| 7(2) | Ms. Minaxi Bhatt | 1126651 | Sell |
| 7(2) | Jon Stelzmiller | 1375837 | Sell |
| 7(2) | Naresh Kumar Gupta | 575075 | Sell |
| 7(2) | Naresh Kumar Gupta | 588905 | Sell |
| 7(2) | Ms. Minaxi Bhatt | 1446317 | Sell |
Annual Reports of Lupin Limited
Investor Complaints of Lupin Limited
Event Calendar of Lupin Limited
| Purpose | Details |
|---|---|
| Results/Dividend | Inter alia, to consider the audited accounts for the year ended March 31, 2011 and recommend dividend, if any. |
| Results/Dividend | Inter alia, to consider stand-alone and consolidated annual audited financial results for the year ended March 31, 2013 and recommend dividend, if any. |
| Results | Inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2013. |
| Results | Inter alia, to consider and take on record unaudited financial results for the quarter ended September 30, 2013. |
| Results/Dividend | Inter alia, to consider and take on record the unaudited financial results for the quarter and nine-month ended December 31, 2013 and the Board shall consider declaration of interim dividend, if any, for the year ending March 31, 2014. |
| Results/Dividend | Interalia, to consider standalone and consolidated annual audited financial results for the year ended March 31, 2014 and recommend final dividend, if any. |
| Results | Inter alia to consider and take on record the unaudited financial results for the quarter ended June 30, 2014. |
| Results | inter alia to consider and take on record the unaudited financial results for the quarter ended September 30, 2014 |
| Results | interalia to consider and take on record the unaudited financial results for the quarter ended December 31, 2014. |
| Results/Dividend | Inter alia, to consider the standalone and consolidated audited financial results for the year ended March 31, 2015 and recommend dividend, if any. |
| Results | inter alia, to consider and take on record unaudited financial results for the quarter ended June 30, 2015. |
| Results | Inter alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2015. |
| Results | inter alia, to consider and take on record the unaudited financial results for the quarter ended December 31, 2015. |
| Results/Dividend | interalia, to consider and take on record the audited standalone and consolidated Financial Results for the year ended March 31, 2016 and recommended dividend, if any. |
| Results | inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2016. |
| Results | inter alia, to consider and take on record the unaudited financial results for the quarter ended September 30, 2016. |
| Results | Inter alia to consider and take on record the unaudited financial results for the quarter ended December 31, 2016 |
| Results/Dividend | To consider and take on record the audited standalone and consolidated financial results for the year ended March 31, 2017 and recommend dividend if any. |
| Results | Inter alia, to consider and take on record the unaudited financial results for the quarter ended June 30, 2017. |
| Results | Inter alia, to consider and take on record unaudited financial results for the quarter ended September 30, 2017. |
| Results | inter alia, to consider and take on record unaudited financial results for the quarter ended December 31 , 2017. |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2018, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2018 and other business matters. |
| Financial Results/Other business matters | To consider and take on record unaudited financial results for the quarter ended September 30, 2018. |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the quarter ended December 31, 2018 and other business matters. |
| Financial Results/Dividend/Other business matters | To consider and approve the audited standalone and consolidated financial results for the year ended March 31, 2019, dividend and other business matters. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters. |
| Financial Results/Other business matters | To consider and take on record unaudited financial results for the quarter ended September 30, 2019 and other business matters. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2019 and other business matters |
| Financial Results/Dividend | To consider and approve the audited standalone and consolidated financial results for the year ended March 31, 2020 and recommend dividend, if any. |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the quarter ended Jun 30, 2020 and other business matters. |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the quarter and nine months ended December 31, 2020 and other business matters. |
| Financial Results/Dividend/Other business matters | To consider and approve the audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2021, dividend and other business matters |
| Financial Results | To consider and approve inter-alia the unaudited standalone and consolidated financial results of the Company for the quarter ended June 30, 2021 and other matters. |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2021 and other business matters. |
| Financial Results/Other business matters | To consider and and take on record the unaudited financial results of the Company for the quarter and nine-months ended December 31, 2021 and other business matters. |
| Financial Results/Other business matters | To consider and take on record unaudited financial results of the Company for the quarter and nine-months ended December 31, 2022. |
| Financial Results/Dividend/Other business matters | To consider and take on record the audited financial results of the Company for the quarter and year ended March 31, 2023, and recommend dividend, if any. |
| Financial Results/Other business matters | To consider and take on record the unaudited financial results ofthe Company for the quarter ended June 30, 2023 and other business matters. |
| Financial Results/Other business matters | To consider and approve the unaudited financial results of the Company for the quarter and half-year ended September 30, 2023 and other business matters. |
| Financial Results/Other business matters | To consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine-months ended December 31, 2023 and other business matters. |
| Financial Results/Dividend/Other business matters | The meeting of the Board of Directors of the Company will be held on Monday, May 6, 2024, inter alia, to consider and take on record audited financial results of the Company for the quarter and year-ended March 31, 2024 and recommend dividend, if any, |
| Financial Results/Other business matters | Considering and taking on record the unaudited financial results of the Company for the quarter ended June 30, 2024 and other business matters. |
| Financial Results/Other business matters | Board Meeting Intimation for considering and taking on record the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024 and other business matters. |
| Financial Results/Other business matters | To consider and approve the unaudited Standalone and Consolidated financial results for the quarter and nine months ended December 31, 2024 and other business matters. |
Share Transfers of Lupin Limited
Voting Results of Lupin Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 02-AUG-2024 | AGM | To adopt the standalone audited financial statements including Balance Sheet as at March 31, 2024, Statement of Profit and Loss for the year ended on that date together with notes forming part of it, Cash Flow Statement for the said year and Reports of the Board of Directors and Auditors thereon. |
| 02-AUG-2024 | AGM | To ratify the remuneration payable to Mr. S. D. Shenoy, Cost Auditor, for conducting cost audit for the year ending March 31, 2025. |
| 02-AUG-2024 | AGM | To pay commission to non-executive directors of the Company not exceeding in the aggregate 1% of the Company's standalone net profit, computed in the manner laid down by Section 198 of the Companies Act, 2013 and Rules made thereunder. |
| 02-AUG-2024 | AGM | To appoint Mr. Alfonso Zulueta (DIN: 10597962), as an Independent Director of the Company for a period of five years effective May 6, 2024. |
| 02-AUG-2024 | AGM | To appoint Mr. Jeffrey Kindler (DIN: 10592395), as an Independent Director of the Company for a period of five years effective May 6, 2024. |
| 02-AUG-2024 | AGM | To approve continuation of directorship of Mrs. Manju D. Gupta (DIN: 00209461), Chairman, Non-Executive Director on existing terms of her appointment. |
| 02-AUG-2024 | AGM | To re-appoint Mr. Nilesh D. Gupta (DIN: 01734642), as a Director of the Company, who retires by rotation and being eligible, offers himself, for re-appointment. |
| 02-AUG-2024 | AGM | To declare dividend of Rs. 8/- per equity share, for the year ended March 31, 2024. |
| 02-AUG-2024 | AGM | To adopt the consolidated audited financial statements including Balance Sheet as at March 31, 2024, Statement of Profit and Loss for the year ended on that date together with notes forming part of it, Cash Flow Statement for the said year and Report of the Auditors thereon. |
| 03-AUG-2023 | AGM | To adopt the standalone audited financial statements including Balance Sheet as at March 31, 2023, Statement of Profit and Loss for the year ended on that date together with notes forming part of it, Cash Flow Statement for the said year and Reports of the Board of Directors and Auditors thereon. |
| 03-AUG-2023 | AGM | To ratify the remuneration payable to Mr. S. D. Shenoy, Cost Auditor, for conducting cost audit for the year ending March 31, 2024. |
| 03-AUG-2023 | AGM | To approve the continuation of non-executive directorship of Mr. Jean-Luc Belingard, Independent Director (DIN: 07325356), who shall attain the age of 75 years on October 28, 2023. |
| 03-AUG-2023 | AGM | To re-appoint Mr. Nilesh D. Gupta (DIN: 01734642), as Managing Director of the Company for a period of five years effective September 1, 2023. |
| 03-AUG-2023 | AGM | To re-appoint Mr. Ramesh Swaminathan (DIN: 01833346), as a Director of the Company, who retires by rotation and being eligible, offers himself, for re-appointment. |
| 03-AUG-2023 | AGM | To declare dividend of ￂ 4/- per equity share of the face value of ￂ 2/- each, for the year ended March 31, 2023. |
| 03-AUG-2023 | AGM | To adopt the consolidated audited financial statements including Balance Sheet as at March 31, 2023, Statement of Profit and Loss for the year ended on that date together with notes forming part of it, Cash Flow Statement for the said year and Report of the Auditors thereon. |
| 03-AUG-2022 | AGM | To adopt the Standalone audited financial statements including Balance Sheet as at March 31, 2022, Statement of Profit and Loss and Cash Flow Statement for the year ended on that date and Reports of the Board of Directors and Auditors thereon. |
| 03-AUG-2022 | AGM | To re-appoint Ms. Vinita Gupta (DIN: 00058631), as a Director of the Company, who retires by rotation and being eligible, offers herself, for re-appointment. |
| 03-AUG-2022 | AGM | To declare dividend of ￂ 4 per equity share, for the year ended March 31, 2022. |
| 03-AUG-2022 | AGM | To adopt the Consolidated audited financial statements including Balance Sheet as at March 31, 2022, Statement of Profit and Loss and Cash Flow Statement for the year ended on that date and Reports of the Board of Directors and Auditors thereon. |
FAQs on Lupin Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.